SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001741830-22-000035
Filing Date
2022-11-08
Accepted
2022-11-08 16:02:58
Documents
67
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q kron-20220930.htm   iXBRL 10-Q 1569519
2 EX-31.1 kronq3fy2022ex311.htm EX-31.1 20300
3 EX-31.2 kronq3fy2022ex312.htm EX-31.2 20265
4 EX-32.1 kronq3fy2022ex321.htm EX-32.1 11502
10 GRAPHIC kron-20220930_g1.jpg GRAPHIC 70581
  Complete submission text file 0001741830-22-000035.txt   6147360

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kron-20220930.xsd EX-101.SCH 35615
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kron-20220930_cal.xml EX-101.CAL 67217
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kron-20220930_def.xml EX-101.DEF 130688
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kron-20220930_lab.xml EX-101.LAB 465478
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kron-20220930_pre.xml EX-101.PRE 292719
61 EXTRACTED XBRL INSTANCE DOCUMENT kron-20220930_htm.xml XML 967698
Mailing Address 1300 S. EL CAMINO REAL SUITE 400 SAN MATEO CA 94402
Business Address 1300 S. EL CAMINO REAL SUITE 400 SAN MATEO CA 94402 212-871-7920
Kronos Bio, Inc. (Filer) CIK: 0001741830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39592 | Film No.: 221368778
SIC: 2834 Pharmaceutical Preparations